NEFL and amyotrophic lateral sclerosis: Moreover, as mentioned previously, more studies show that NfL is a reliable biomarker with regard to monitoring of ALS, and in the future, it would be relevant to assess, how T‐SICIp performs as a longitudinal biomarker.